Literature DB >> 24743221

Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature.

Sanam Loghavi1, Jonathan L Curry1, Carlos A Torres-Cabala1, Doina Ivan1, Keyur P Patel2, Meenakshi Mehrotra2, Roland Bassett3, Victor G Prieto1, Michael T Tetzlaff1.   

Abstract

Melanomas arising in association with blue nevi or mimicking cellular blue nevi comprise a relatively rare and heterogeneous group of melanomas. It remains controversial which prognostic indicators predictive of outcome in conventional cutaneous melanomas are applicable to this type of melanoma. Here, we describe the clinical and histopathologic features of 24 melanomas arising in association with blue nevi and correlate these with clinical outcome. The mean patient age was 49 years (range: 23-85) with a slight female predominance (15 females:9 males). The most common anatomic locations included the head and neck region (50%), the trunk (21%), and the buttock/sacrococcygeum (17%). Histologically, the tumors were typically situated in the mid to deep dermis with variable involvement of the subcutis, but uniformly lacked a prominent intraepithelial component. The mean tumor thickness (defined as either the standard Breslow thickness or, if not available due to the lack of orientation or lack of epidermis, the largest tumor dimension) was 20.9 mm (range: 0.6-130 mm). The mean mitotic figure count was 6.5/mm(2) (range: 1-30/mm(2)). Perineural invasion was common (38%). Follow-up was available for 21 cases (median 2.1 years). The median overall survival, recurrence-free survival, time to local recurrence, and time to distant recurrence were 5.2, 0.7, 2.6, and 1.6 years, respectively. Logistic regression analyses demonstrated a significant association between tumor thickness and recurrence-free survival (hazard ratio=1.02 per mm; P=0.04) and reduced time to distant metastasis (hazard ratio=1.03 per mm; P=0.02) with a similar trend toward reduced time to local recurrence (hazard ratio=1.02 per mm; P=0.07). No other parameters (age, anatomic location, mitotic figures, lymphovascular or perineural invasion, or type of associated blue nevus) emerged as significant. In addition, we provide a comprehensive review of 109 cases of melanoma blue nevus type described in the English literature and summarize our findings in this context.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24743221     DOI: 10.1038/modpathol.2014.62

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

1.  Molecular alterations in malignant blue nevi and related blue lesions.

Authors:  Ismail Yilmaz; Mehmet Gamsizkan; Sule Ozturk Sari; Banu Yaman; Cuyan Demirkesen; Aylin Heper; Aylin Orgen Calli; Gizem Narli; Zafer Kucukodaci; Ufuk Berber; Dilaver Demirel; Taner Akalin; Murat Demiriz; Nesimi Buyukbabani
Journal:  Virchows Arch       Date:  2015-09-24       Impact factor: 4.064

2.  SF3B1 and BAP1 mutations in blue nevus-like melanoma.

Authors:  Klaus G Griewank; Hansgeorg Müller; Louise A Jackett; Michael Emberger; Inga Möller; Johannes Ap van de Nes; Lisa Zimmer; Elisabeth Livingstone; Thomas Wiesner; Simone L Scholz; Ioana Cosgarea; Antje Sucker; Tobias Schimming; Uwe Hillen; Bastian Schilling; Annette Paschen; Henning Reis; Thomas Mentzel; Heinz Kutzner; Arno Rütten; Rajmohan Murali; Richard A Scolyer; Dirk Schadendorf
Journal:  Mod Pathol       Date:  2017-04-14       Impact factor: 7.842

3.  [Tumors of the scalp: special aspects of selected examples].

Authors:  C Rose
Journal:  Hautarzt       Date:  2014-12       Impact factor: 0.751

4.  Genomic copy number analysis of a spectrum of blue nevi identifies recurrent aberrations of entire chromosomal arms in melanoma ex blue nevus.

Authors:  May P Chan; Aleodor A Andea; Paul W Harms; Alison B Durham; Rajiv M Patel; Min Wang; Patrick Robichaud; Gary J Fisher; Timothy M Johnson; Douglas R Fullen
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

5.  Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue nevi.

Authors:  Inga Möller; Rajmohan Murali; Hansgeorg Müller; Thomas Wiesner; Louise A Jackett; Simone L Scholz; Ioana Cosgarea; Johannes Ap van de Nes; Antje Sucker; Uwe Hillen; Bastian Schilling; Annette Paschen; Heinz Kutzner; Arno Rütten; Martin Böckers; Richard A Scolyer; Dirk Schadendorf; Klaus G Griewank
Journal:  Mod Pathol       Date:  2016-12-09       Impact factor: 7.842

Review 6.  Biologically distinct subsets of nevi.

Authors:  Tova Rogers; Maria L Marino; Patricia Raciti; Manu Jain; Klaus J Busam; Michael A Marchetti; Ashfaq A Marghoob
Journal:  G Ital Dermatol Venereol       Date:  2016-04-27       Impact factor: 2.011

Review 7.  Melanoma Ex Blue Nevus With GNA11 Mutation and BAP1 Loss: Case Report and Review of the Literature.

Authors:  Li-Wei Chang; Viktoryia Kazlouskaya; Rashek Kazi; Diwakar Davar; Robert L Ferris; Jonhan Ho; Arivarasan Karunamurthy; Jaroslaw J Jedrych; Yuri L Bunimovich
Journal:  Am J Dermatopathol       Date:  2020-11       Impact factor: 1.319

8.  Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway.

Authors:  Mileidys Pérez-Alea; Ana Vivancos; Ginevra Caratú; Judit Matito; Berta Ferrer; Javier Hernandez-Losa; Javier Cortés; Eva Muñoz; Vicente Garcia-Patos; Juan A Recio
Journal:  Oncotarget       Date:  2016-05-10

9.  Metastatic Blue Nevus-Like Melanoma Detected by Liquid-Based Catheterized Urine Cytology.

Authors:  Sue Kyung Kim; Ji Young Yang; Jae Ho Han; Ji Eun Kwon
Journal:  Ann Dermatol       Date:  2018-04-23       Impact factor: 1.444

Review 10.  Primary orbital melanoma arising in an atypical diffuse (plaque-like) blue naevus/melanocytosis: a case report and review of literature.

Authors:  Tracey-Anne Dickens; Maria Franchina; Adam Gajdatsy; Nima Mesbah Ardakani
Journal:  BMC Ophthalmol       Date:  2021-12-09       Impact factor: 2.209

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.